Glenbeigh is pleased to announce the publication of a study conducted by Dr. Carolanne Semancik, Manager of Quality, Risk Management, and Training. Dr. Semancik conducted an in-depth examination of records over an eight-month period, from July 2023 to February 2024. The study provides early evidence supporting a previously theorized connection between certain substance exposures and wound development.
The pain associated with these wounds can lead to an unfortunate cycle in which individuals may engage in behaviors to temporarily alleviate pain, potentially exacerbating wound complications.
The study identified a statistically significant association between specific substance exposures and an increased prevalence of wounds. Individuals with certain exposures were found to be significantly more likely to develop wounds compared to those without such exposures. This research emphasizes the importance of equipping professionals who work with individuals with substance use disorders to recognize and address the potential for an increased occurrence of wounds associated with certain substance exposures.
Further research is needed to investigate the mechanisms by which these exposures affect soft tissue, potentially making individuals more susceptible to wound development.
The publication of this study in the prestigious Journal of Addiction Medicine is a significant achievement, highlighting Dr. Semancik's dedication to advancing our understanding of substance use disorders and their associated complications. Glenbeigh congratulates Dr. Semancik on this well-deserved recognition and her invaluable contributions to the field of addiction medicine.
Read the full study at the Journal of Addiction Medicine.